Rabies: The Near-Certain Killer That Exploits the Nervous System
Translated & summarized from Israel Hayom by baba
Rabies is a viral disease with a 99.9% fatality rate once symptoms appear, as the virus travels through the nervous system to the brain. While largely eradicated in domestic dogs in the West, it remains a threat from wildlife like bats, whose bites can be unnoticed. Prompt post-exposure prophylaxis before symptom onset is 100% effective, but treatment after symptoms emerge is almost always fatal. Louis Pasteur developed the first vaccine in 1885, and a rare survival case in 2004 involved an experimental "Milwaukee Protocol."
The story in 6 lines · by baba
- Rabies has a 99.9% fatality rate once clinical symptoms appear, making it one of the deadliest infectious diseases.
- The virus travels through the nervous system to the brain, evading immune detection by entering nerve cells.
- While domestic dog rabies is reduced in the West, bats are now a primary source of human infection.
- Prompt post-exposure prophylaxis (PEP) before symptoms is 100% effective in preventing rabies.
- The experimental "Milwaukee Protocol" led to a rare survival in 2004 but has largely failed since.
- Louis Pasteur developed the first rabies vaccine in 1885, a major breakthrough in combating the disease.
Rabies, an ancient and terrifying virus, boasts a near-unmatched fatality rate of 99.9% once clinical symptoms appear. Unlike viruses like Ebola or smallpox, rabies employs a unique strategy: it doesn't directly attack the immune system but instead hijacks the nervous system. Upon infection, typically through a bite, the virus travels along nerve pathways to the spinal cord and then to the brain. This journey is facilitated by a "Trojan Horse" mechanism, where the virus enters nerve cells and is transported internally, shielded from immune system detection due to the brain's "immune privilege."
The incubation period can vary from weeks to over a year, during which the infected individual feels no symptoms. The disaster strikes when the virus reaches the brainstem and central nervous system, causing rapid multiplication and affecting critical functions like breathing and swallowing. Symptoms such as hydrophobia, an extreme aversion to water, are not mere side effects but a calculated manipulation by the virus to ensure its transmission through saliva.
Historically, rabies was considered a death sentence. However, in 2004, a 15-year-old girl named Gina Geske survived after being bitten by a bat. Doctors administered an experimental treatment, the "Milwaukee Protocol," which involved inducing a deep coma to allow her immune system time to fight the virus. While this case offered a glimmer of hope, subsequent attempts to replicate the protocol have largely failed, with over 90% of patients still succumbing to the disease.
While rabies has been largely eradicated from domestic dogs in many Western countries due to vaccination programs, the threat persists from wildlife, particularly bats. Their small, sharp teeth can inflict bites that are often unnoticed, especially in sleeping individuals. Health organizations worldwide, including the CDC and Israel's Ministry of Health, emphasize that any potential exposure to a bat, especially if found in a bedroom with a sleeping person or unattended child, should be treated as a definite rabies exposure, necessitating immediate preventive treatment.
The key to survival lies in prompt post-exposure prophylaxis (PEP) before symptoms manifest. This treatment involves thorough wound cleaning, passive immunization with antibodies, and a series of active vaccinations. The historical breakthrough in rabies treatment came in 1885 with Louis Pasteur's development of the first vaccine, successfully tested on a boy named Joseph Meister, marking a pivotal moment in combating this deadly pathogen.